DUDLEY CLINICAL COMMISSIONING GROUP BOARD AGENDA Thursday, 2 May 2013 1.00pm – 4.05pm at the Boardroom Kings House, Dudley, DY2 8PE Presented Time Agenda Item Attachment By 1 pm 1. Apologies 1 pm 2. Declarations of Interest To request members to disclose any interest they have, direct or indirect, in any items to be considered during the course of the meeting and to note that those members declaring an interest would not be allowed to take part in the consideration for discussion or vote on any questions relating to that item. 3. Minutes from meeting 7 March 2013 Enclosed Dr Hegarty 4. Matters Outstanding Enclosed Dr Hegarty 5. Questions from the Public To respond to questions from members of the public present at the meeting on the provision of health care to the population served by the CCG. 1.05pm 6. Chairman’s & Chief Officer Report Verbal Mr P Maubach 6.1 Report 1.15pm 7. Patient Experience Story Presentation Dr L Pope 8. Quality & Safety 1.35pm 8.1 Presentation from DGFT on Mortality Presentation Mr R Calender 1.50pm 8.2 CCG Response to Francis Report Enclosed Miss Bartholomew 2.05pm 8.3 Report from Quality and Safety Committee Enclosed Dr L Pope 9. Commissioning 2.15pm 9.1 Report from Clinical Development Committee Enclosed Dr S Mann 2.25pm 9.2 Update from Health & Well Being Board Enclosed Mr N Bucktin 2.35pm 9.3 Agreements Made Under Section 75 of The Health Act Enclosed Mr N Bucktin 2006 10. Communications & Engagement 2.45pm 10.1 Communications & Engagement Update Enclosed Mrs J Jasper 11. Governance 2.55pm 11.1 Report from Audit Committee Enclosed Mrs J Jasper 3.05pm 11.2 Black Country Cluster Handover Document Enclosed Mr M Hartland 3.15pm 11.3 Risk Management Strategy Enclosed Mr M Hartland 3.25pm 11.4 Black Country Assurance Framework Enclosed Mr M Hartland 3.35pm 11.5 Risk Register Dudley CCG Agenda – 2 May 2013 1 | Page 12. Finance and Performance 3.45pm 12.1 Report from Finance & Performance Committee Enclosed Dr J Rathore 13. Primary Care 3.55pm 13.1 Report from Primary Care Development Committee Enclosed Dr J Rathore 4.05pm Close 14. For Information 14.1 Glossary Enclosed Time & Date of next meeting Thursday 4th July 2013, 1pm Venue: to be confirmed Dudley CCG Agenda – 2 May 2013 2 | Page Enclosure 1 DUDLEY CLINICAL COMMISSIONING GROUP BOARD PUBLIC MINUTES OF THE MEETING HELD IN PUBLIC ON THURSDAY, 7 MARCH 2013 AT 1.00 PM, BOARDROOM KINGS HOUSE ATTENDEES: Miss R Bartholomew Head of Nursing, Quality & Patient Safety Dr J Darby GP Board Member (Halesowen & Quarry Bank) Dr K Dawes GP Board Member (Sedgley, Coseley, Gornal) Dr R Edwards GP Board Member (Kingswinford, Amblecote & Brierley Hill) Dr P D Gupta GP Board Member (Dudley & Netherton) Mr M Hartland Chief Finance Officer Dr M Heber Secondary Care Clinician Dr D Hegarty GP Board Member (Chair of CCG) Dr T Horsburgh LMC Representative Mrs J Jasper Lay Member – Patient & Public Engagement Dr R Johnson GP Board Member (Halesowen & Quarry Bank) Ms V Little Director of Public Health, Dudley PCT Dr S Mann Clinical Executive – Acute & Community Commissioning Mr P Maubach Chief Officer, Dudley CCG Dr N Plant Clinical Executive – Partnership Commissioning Mr J Polychronakis Chief Executive Officer, Dudley MBC Dr J Rathore Clinical Executive – Finance & Performance IN ATTENDANCE: Mrs L Broster Head of Communications Mr N Bucktin Head of Partnership Commissioning Mr P Capener Interim Governance Support Mrs S Cartwright Organisational Development Lead Dr R Gee GP Engagement Lead Mr A Gray Healthwatch Dudley Mrs C Gower Office Manager, Minutes, Dudley CCG Mrs A Tennant Head of Service Improvement & Quality APOLOGIES FOR ABSENCE: Mr J Hall ICM, Dudley CCG Dr M Mahfouz GP Board Member (Dudley & Netherton) Dr L Pope Clinical Executive – Quality & Safety Mr S Wellings Lay Member – Governance (in the Chair) MEMBERS OF THE PUBLIC/PRESS: There were 7 members of the public present Dr Hegarty welcomed Mr Andy Gray who was attending as a representative for Healthwatch Dudley. 1 | P a g e 24/2013 DECLARATIONS OF INTEREST 6/2 Members were asked to disclose any interest they may have, direct or indirect, in any of the items to be considered during the course of the meeting and to note that those Members declaring an interest would not be allowed to take part in the consideration or discussion or vote on any questions relating to that item. Declaration of interest was declared from Ms Little and Mr Polychronakis regarding Item 13.1, Primary Care Development Committee. Declaration of interest was declared from all GPs present regarding item 13.1 on the recommendation for LES extension to September 2013. 25/2013 MINUTES OF THE MEETING HELD ON 3 JANUARY 2013 Accepted as a true and correct record. Dr Dawes noted that he was present at this meeting on 3 January 2013. 2 | P a g e 26/2013 MATTERS OUTSTANDING CLINICAL COMMISSIONING GROU THURSDAY 7 MARCH 2013 Action Issue Action For Deadline Comments Number Dr Pope to raise issue around 126/2012 Update confidentiality in relation to LP REMAIN AS AN ACTION March 2013 carers strategy 3 | P a g e 27/2013 QUESTIONS FROM THE PUBLIC No questions from the public were received. FOCUS ON THE PATIENT VOICE 28/2013 GILLIAN’S STORY There was a 10 minute film featuring a patient’s experience in the acute and community environments. There was no discussion following the film. CHAIRMAN’S & CHIEF OFFICER REPORT 29/2013 REPORT The areas covered in Mr Maubach’s verbal report were as follows: • Authorisation. The new independent NHS Commissioning Board announced on Tuesday 11 December 2012 that Dudley CCG has been authorised with 2 conditions. The work on these conditions has now been completed, re-submitted and accepted. • Francis Report. More detailed work with the Commissioning Board remains outstanding. The CCG will be focusing on this over the next 2 months. • Preparation for 1st April 2013. Contracts with providers are on target and on time. The only delay is in relation to the Commissioning Board regarding Specialised Services. • Operational Issues. There are concerns around the high level of Urgent Care demand at Dudley Group (DGoH). There have been several occasions when they have reached escalation Level 4 (their highest level). This is partly due to issues around delayed transfer of care into the Local Authority (LA), however these issues have been eased following discussions with colleagues in the LA. Mr Maubach gave assurance that all colleagues concerned were co-operating in addressing the issues and pressures and wished to acknowledge the success of joint partnership working. It was also noted that these issues are not just related to Dudley they are across the West Midlands. Resolved: 1. The Board noted the report for assurance 2. COMMISSIONING 3. 4 | P a g e QUALTIY AND SAFETY 30/2013 REPORT FROM QUALITY AND SAFETY COMMITTEE Miss Bartholomew presented this report to the Board on behalf of Dr Pope for assurance that the Quality and Safety Committee are effectively responding to and acting upon quality concerns within the Dudley Health Economy. The report provides details and update of the key topics discussed at the most recent Quality & Safety Committee meeting held on 11 February 2013. Miss Bartholomew highlighted the planned themed visits mentioned in the report, the Tissue Viability themed visit to be undertaken at Dudley Group Foundation Trust (DGFT) plus the absconds/suicides and children being placed on adult wards themed visit which is being undertaken with Dudley and Walsall Mental Health Partnership Trust (DWMHPT). Regarding the latter visit, Dr Horsburgh informed that Walsall have recently received funding for Tier 3 Care at Home, which could be a solution for Dudley. Resolved: 1. The Board agreed to accept the report for assurance 31/2013 RESPONSE TO THE FRANCIS REPORT Miss Bartholomew updated the Board of the progress and the response to date to the recent publication of the Francis Report. The Report includes 290 recommendations and has far reaching implications for the health economy and the appropriate governance of organisations. There are National, Local, Local Authority and organisational implications. The key points Miss Bartholomew highlighted were the proposed approach to the response to the Report, the warning signs which are as follows: • Failure to meet targets- elective surgery • Outpatient waiting times, cancer waiting times and financial performance • National Reviews, lack of data submitted was the excuse • E.g. Cancer Peer Review- Unclear who has responsibility for following up peer review. • Auditors report on risk management and assurance system • Annual surveys of staff and patients, the voice of the local community • Whistle blowing- Allegations about leadership • Royal college Review • Quality Impact Assessment of the cost improvement programmes • Foundation Trust status – communication between all regulators around the table • Everybody waiting for the formal investigation, no consideration of action for themselves. The other key point highlighted was the format of the forthcoming visit to Dudley Group Foundation Trust which will be a review into the quality of care and treatment provided along with 13 other Trusts in England. The 14 hospital trusts will be investigated as part of the review on the basis that they have been outliners for the last two consecutive years on either the Summery Hospital Level Mortality Indicator or the Hospital Standardised Mortality Ratio. Mr Polychronakis highlighted that a measured response and defined outcomes were critical and the important issues only should be concentrated on in the response. 5 | P a g e Miss Bartholomew assured that her team would continue with their current approach to their response and will present further at the next Board.